ORCA Study: Osteoarthritis and Risks Associated With the Consumption of NSAIDs
NCT04099459 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1250
Last updated 2019-09-23
Summary
Cross-sectional epidemiological study in patients with diagnosis of osteoarthritis (OA) in order to evaluate risk factors associated with the use / prescription of non-steroidal anti-inflammatory drugs (NSAID).
Conditions
Sponsors & Collaborators
-
Scandinavia Pharma
lead INDUSTRY
Principal Investigators
-
Javier Castillo, Dr · Medical Director
Eligibility
- Min Age
- 38 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-10
- Primary Completion
- 2023-12-31
- Completion
- 2024-07-31
Countries
- Colombia
Study Locations
More Related Trials
-
Feasibility Study of Anti-inflammatory Cytokines in Whole Blood in Osteoarthritis Patients
NCT01050894 ·Status: COMPLETED
-
Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
NCT05430230 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee
NCT00211549 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Diclofenac Capsules to Treat Osteoarthritis Pain
NCT01461369 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Follow-up of Synvisc® in Active Patients With Knee Osteoarthritis
NCT02195492 ·Status: COMPLETED
-
Osteoarthritis Initiative (OAI): A Knee Health Study
NCT00080171 ·Status: COMPLETED
-
A Clinical Study to Investigate the Effect on Pain Relief of a Single Dose of JNJ-39439335 in Patients With Chronic Osteoarthritis Pain of the Knee
NCT00933582 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)
NCT00250445 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee
NCT00265304 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Oral Salmon Calcitonin in Human Osteoarthritis
NCT00376311 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee
NCT00979953 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Follow-up Study of Synvisc® in Patients With Knee Osteoarthritis
NCT02195557 ·Status: COMPLETED
-
Epidemiology of Osteoarthritis (OA) Pain
NCT01557231 ·Status: COMPLETED
-
2ccPA Study in Patients With Symptomatic Knee Osteoarthritis
NCT04229394 ·Status: COMPLETED ·Phase: PHASE1
-
Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
NCT00141102 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee
NCT00689273 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Effect of Chondroitin Sulfate on Structural Changes in Knee Osteoarthritis Patients Assessed by MRI
NCT01354145 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee
NCT01529671 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Clinical Investigation of Arthrosamid in Knee Osteoarthritis
NCT05057559 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA)
NCT01967550 ·Status: COMPLETED ·Phase: PHASE3
-
Study of FX005 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
NCT01291914 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee
NCT00722852 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Synvisc® in Knee Osteoarthritis - Survey on Practice
NCT02195544 ·Status: COMPLETED
-
An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint
NCT06485843 ·Status: RECRUITING ·Phase: PHASE2
-
Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)
NCT00092703 ·Status: COMPLETED ·Phase: PHASE3